An invention by Finnish company Askel Healthcare aims to overcome joint pain and rebuild cartilage to avoid osteoarthritis
Helsinki, 13 January 2020 – Askel Healthcare Ltd , a Finnish biotechnology company, is on a mission to overcome the need for total joint replacements. Askel’s deep tech solution focuses on early intervention and prevention of joint surface degradation. Askel’s solution, COPLA®, is a medical device used as a cartilage lesion filler that offers the required properties for cartilage regeneration enabling cartilage repair before osteoarthritic changes occur. COPLA® is already in use for the benefit of veterinary patients. The next step is to